QuantuMDx logo
  • Multiplex Diagnostics Products
    • Platforms
    • Assays
  • Innovations
    • Antimicrobial Resistance
    • Sexually Transmitted Infections
    • Collaborations
  • About Us
    • Our Company
    • Leadership Team
    • Careers
    • Quality
    • Sustainability
  • Insights
    • Publications
  • Contact Us
SARS-CoV-2 RT-PCR Detection Assay  receives CTDA legislation approval

SARS-CoV-2 RT-PCR Detection Assay receives CTDA legislation approval

by QuantuMDx Team | Mar 10, 2022 | News

NEWCASTLE UPON TYNE, UK, 10 MARCH 2022. QuantuMDx Group Limited (“QuantuMDx”), today announces that its SARS-CoV-2 RT -PCR detection assay, has been approved in the UK under the UK Health Security Agency’s Medical Devices (Coronavirus Test Device Approvals)...
Q-POC™ SARS-CoV-2 assay receives CTDA legislation approval

Q-POC™ SARS-CoV-2 assay receives CTDA legislation approval

by QuantuMDx Team | Feb 22, 2022 | News

NEWCASTLE UPON TYNE, UK, 22 FEBRUARY 2022. QuantuMDx Group Limited (“QuantuMDx”), today announces that its rapid PCR SARS-CoV-2 test, with the multiplex Q-POC™ platform, has been approved for continued sales in the UK under the UK Health Security Agency’s Medical...
Are the new COVID-19 rules a mixed blessing for care homes?

Are the new COVID-19 rules a mixed blessing for care homes?

by QuantuMDx Team | Feb 1, 2022 | Blog

We recently conducted a survey of how the demands of COVID-19 testing had impacted on UK care homes together with Care Home Professional magazine. What we found was shocking: the demands of COVID-19 testing has pushed homes to breaking point. Many staff told us...

Recent Posts

  • World AMR Awareness Week 2024
  • World Patient Safety Day 2024 – How the Q-POC Platform Supports Patient Safety
  • A guide to the UN General Assembly High-Level Meeting on Antimicrobial Resistance 2024
  • The Next Pandemic: Q-POC and Disease X
  • Microarray-Based Technologies in Molecular Diagnostics: A Review

Recent Comments

No comments to show.

Follow Us

  • Follow
  • Follow
  • Follow
  • Follow

Products

QuantuMDx delivers next-generation molecular diagnostics through the Q-POC™ platform and its expanding range of assays — enabling rapid, accurate, and accessible testing for STIs, AMR and more at the point of need.

Support

Distributor Materials

Contact Us

 

QuantumMDx

About Us
Our Company
Our Leadership Team
Quality
Sustainability
Careers

Insights

All Articles
News
Blogs

© 2026 QuantuMDx Group Ltd. — Website by Logic Digital

Sitemap | Terms and Conditions | Privacy | Cookies